/MBAI
MBAI Stock - Check-Cap Ltd. Ordinary Share
Healthcare|Medical - Diagnostics & ResearchNASDAQ
$1.88+5.62%
+$0.10 (+5.62%) • Dec 19
80
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
High Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.100
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $2.07
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for MBAI
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.86 – $1.90
TARGET (TP)$2.16
STOP LOSS$1.73
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.43
52W High$3.13
52W Low$0.56
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A |
| Operating Income | $-25,949,000 | $-19,287,000 | $-20,034,000 | $-17,321,000 |
| Net Income | $-25,149,000 | $-17,568,000 | $-19,108,000 | $-17,202,000 |
| Net Margin | N/A | N/A | N/A | N/A |
| EPS | $-4.30 | $-3.00 | $-3.37 | $-3.03 |
Company Overview
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. The company was incorporated in 2004 and is based in Isfiya, Israel.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
MBAILoading earnings data...
Latest News
Loading news...
Frequently Asked Questions about MBAI
What is MBAI's current stock price?
Check-Cap Ltd. Ordinary Share (MBAI) is currently trading at $1.88 per share. The stock has moved +5.62% today.
What is the analyst price target for MBAI?
No analyst price targets are currently available for this stock.
What sector is Check-Cap Ltd. Ordinary Share in?
Check-Cap Ltd. Ordinary Share operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the NASDAQ exchange.
What is MBAI's market cap?
Check-Cap Ltd. Ordinary Share has a market capitalization of $0.01 billion, making it a small-cap company.
Does MBAI pay dividends?
No, Check-Cap Ltd. Ordinary Share does not currently pay a dividend to shareholders.